LiHChenCHuF, et al.Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Leukemia. 2020:34(6):1–9.
2.
RussellCDMillarJEBaillieJK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473–475.
3.
BertonAMPrencipeNGiordanoRGhigoEGrottoliS. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view. J Endocrinol Invest. 2020:1–3.
4.
WilkinsonE. RECOVERY trial: the UK covid-19 study resetting expectations for clinical trials. Bmj. 2020;369:m1626.
5.
TheoharidesTCContiP. Dexamethasone for COVID-19? Not so fast. J Biol Regul Homeost Agents. 2020;34(3):1241–1243. doi:10.23812/20-EDITORIAL_1-5
6.
RhodesAEvansLEAlhazzaniW, et al.Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552. doi:10.1097/CCM.0000000000002255
7.
WuCChenXCaiY, et al.Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Int Med. 2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994
8.
FadelRMorrisonAVahiaA, et al.Early short course corticosteroids in hospitalized patients with COVID-19. medRxiv. 2020:71(16):2114–2120.
9.
LiuDAhmetAWardL, et al.A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. doi:10.1186/1710-1492-9-30
10.
Tamez-PérezHEQuintanilla-FloresDLRodríguez-GutiérrezRGonzález-GonzálezJGTamez-PeñaAL. Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015;6(8):1073–1081. doi:10.4239/wjd.v6.i8.1073
11.
KlonoffDCUmpierrezGE. Letter to the editor: COVID-19 in patients with diabetes: risk factors that increase morbidity. Metabolism. 2020;108:154224. doi:10.1016/j.metabol.2020.154224
